Breast cancer, Lung cancer, Melanoma, Non small cell lung cancer (NSCLC), Ovarian cancer, Triple negative breast cancer
Open
Phase 1/2
This trial is looking at a new drug called NVG-222 for that have spread to another part of the body.
Recruitment start: 17 September 2026
Recruitment end: 31 January 2032
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor James Spicer
Cancer Research UK
This is Cancer Research UK trial number CRUKD/25/003.
Last reviewed: 21 Sept 2026
CRUK internal database number: 20184
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
